Literature DB >> 501896

A sensitive radioimmunoassay for the determination of plasma angiotensin II in human subjects.

H Kobayashi, K Shimamoto, O Moriguchi, M Miyahara.   

Abstract

A sensitive and specific radioimmunoassay for the determination of plasma angiotensin II was developed by using the antisera against synthetic angiotensin II in combination with labeled angiotensin II. This assay employs an acetone extraction procedure and detects as little as 0.8 pg per tube of angiotensin II. The mean (+/- S.E.) plasma angiotensin II concentration in 19 normal subjects was 14.4 +/- 1.8 pg/ml in a state of overnight fasting and recumbency. In 13 normal subjects, in whom 40 mg of furosemide was injected intravenously, plasma angiotensin II concentration before and after 30 and 120 minutes in an upright position was 14.6 +/- 2.2, 56.6 +/- 5.7 and 74.3 +/- 9.0 pg/ml, respectively. In 6 normal subjects, an infusion of isotonic saline, angiotensin II concentration reduced from 14.1 +/- 3.7 to 9.2 +/- 1.7 pg/ml. Thus, it was ascertained that the simplified radioimmunoassay method reported here using an acetone-petroleum ether extraction method was specific and highly sensitive.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 501896     DOI: 10.1253/jcj.43.727

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  2 in total

1.  Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.

Authors:  Shigetaka Yoshida; Kenichi Ishizawa; Nobuhiro Ayuzawa; Kohei Ueda; Maki Takeuchi; Wakako Kawarazaki; Toshiro Fujita; Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2013-10-24       Impact factor: 2.801

2.  Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

Authors:  H Funatsu; H Yamashita; Y Nakanishi; S Hori
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.